相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B-cell-depleting Therapy in Systemic Lupus Erythematosus
Manuel Ramos-Casals et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
Giuseppe Nocentini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Soluble CD40 Ligand (sCD40L) Provides a New Delivery System for Targeted Treatment sCD40L-Caspase 3 Chimeric Protein for Treating B-Cell Malignancies
Rotem Kedar et al.
CANCER (2012)
BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus
Kirsten Fairfax et al.
IUBMB LIFE (2012)
Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL)
C. Buechele et al.
LEUKEMIA (2012)
Reverse signaling through the Co-Stimulatory Ligand, CD137L, as a critical mediator of sterile inflammation
Sang Jun Park et al.
MOLECULES AND CELLS (2012)
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
David L. Lacey et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Requirement of Transmembrane Domain for CD154 Association to Lipid Rafts and Subsequent Biological Events
Nadir Benslimane et al.
PLOS ONE (2012)
Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand
Byungsuk Kwon
Immune Network (2012)
4-1BB signaling beyond T cells
Dass S. Vinay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Insights into the molecular regulation of FasL (CD178) biology
Marcus Lettau et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
CD40 translocation to lipid rafts: Signaling requirements and downstream biological events
Amal Nadiri et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
T Cell Costimulation Blockade and Organ Transplantation: A Change of Philosophy for Transplant Immunologists?
Daniel R. Goldstein
JOURNAL OF IMMUNOLOGY (2011)
CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction
Zhe Shao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages
Jung Dae Kim et al.
Immune Network (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic Modulation
Theresa Placke et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
CD137 ligand signaling induces human monocyte to dendritic cell differentiation
Shaqireen M. M. Kwajah et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells
Sung-Tak Jeon et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
CD30 Ligand/CD30 Plays a Critical Role in Th17 Differentiation in Mice
Xun Sun et al.
JOURNAL OF IMMUNOLOGY (2010)
Transmembrane TNF-α: structure, function and interaction with anti-TNF agents
Takahiko Horiuchi et al.
RHEUMATOLOGY (2010)
Outside-to-Inside Signaling Through Transmembrane Tumor Necrosis Factor Reverses Pathologic Interleukin-1β Production and Deficient Apoptosis of Rheumatoid Arthritis Monocytes
Undine Meusch et al.
ARTHRITIS AND RHEUMATISM (2009)
The TNF superfamily in 2009: new pathways, new indications, and new drugs
Malu G. Tansey et al.
DRUG DISCOVERY TODAY (2009)
Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells
Mingxia Yu et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: Involvement of mTOR/p70S6 kinase and Akt
Dong-Ku Kim et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling
Songwen Ju et al.
INTERNATIONAL IMMUNOLOGY (2009)
Leader sequence is required for activity of transmembrane tumor necrosis factor-α
Fang Zheng et al.
MOLECULAR IMMUNOLOGY (2009)
Analysis of Apoptosis in Peripheral Blood and Synovial Tissue Very Early After Initiation of Infliximab Treatment in Rheumatoid Arthritis Patients
Carla A. Wijbrandts et al.
ARTHRITIS AND RHEUMATISM (2008)
Transmembrane TNF-alpha mediates forward and reverse signaling, inducing cell death or survival via the NF-kappa B pathway in Raji Burkitt lymphoma cells
Hailong Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Reverse signaling initiated from GITRL induces NF-kappa B activation through ERK in the inflammatory activation of macrophages
Eun Mi Bae et al.
MOLECULAR IMMUNOLOGY (2008)
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury
Giuseppe Nocentini et al.
MOLECULAR PHARMACOLOGY (2008)
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNFα
Marina Mata et al.
NEUROSCIENCE LETTERS (2008)
A new class of reverse signaling costimulators belongs to the TNF family
Mingyi Sun et al.
JOURNAL OF IMMUNOLOGY (2007)
Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells
Manuela Rossol et al.
JOURNAL OF IMMUNOLOGY (2007)
The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells
V. Kirkin et al.
CELL DEATH AND DIFFERENTIATION (2007)
Signal transduction mechanisms of CD137 ligand in human monocytes
Liane Soellner et al.
CELLULAR SIGNALLING (2007)
Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling
Carlos Reyes-Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of ADAM17 in the ectodomain shedding of TNF-α and its receptors by neutrophils and macrophages
Jessica H. Bell et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Ursula Grohmann et al.
NATURE MEDICINE (2007)
Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes
Junichiro Irie et al.
DIABETES (2007)
Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation
Salvatore Cuzzocrea et al.
FASEB JOURNAL (2007)
Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells
Hyun-Hee Shin et al.
BONE (2006)
The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse
M Lettau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells
P Secchiero et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production
HH Shin et al.
FEBS LETTERS (2006)
A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer
JJ Body et al.
CLINICAL CANCER RESEARCH (2006)
Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism
M Nakamura et al.
RHEUMATOLOGY (2006)
Contribution of TNF-α converting enzyme and proteinase-3 to TNF-α processing in human alveolar macrophages
L Armstrong et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Deciphering CD30 ligand biology and its role in humoral immunity
Mary K. Kennedy et al.
IMMUNOLOGY (2006)
Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL
W Baum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma
DP Xu et al.
GENE THERAPY (2005)
Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40
CL Law et al.
CANCER RESEARCH (2005)
Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells
NK Vudattu et al.
IMMUNOLOGY (2005)
Effects of elastase and cathepsin G on the levels of membrane and soluble TNFα
R Mezyk-Kopec et al.
BIOLOGICAL CHEMISTRY (2005)
Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-κB ligand (RANKL) in osteoclast cells
HH Shin et al.
BONE (2005)
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints - Extended report
AI Catrina et al.
ARTHRITIS AND RHEUMATISM (2005)
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-α
H Mitoma et al.
GASTROENTEROLOGY (2005)
Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis
K Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Efficacy and safety of ABI793, a novel human antihuman CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation
W Schuler et al.
TRANSPLANTATION (2004)
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway
S Kirchner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells
CR Yang et al.
CELL DEATH AND DIFFERENTIATION (2004)
Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease
M Ringheanu et al.
INFLAMMATORY BOWEL DISEASES (2004)
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates
GA Roth et al.
TRANSPLANTATION (2004)
Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes
S Kirchner et al.
CYTOKINE (2004)
Costimulation blockade in the treatment of rheumatic diseases
SNC Liossis et al.
BIODRUGS (2004)
4-1BB-mediated immunotherapy of rheumatoid arthritis
SK Seo et al.
NATURE MEDICINE (2004)
A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL
SW Ju et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?
M Croft
NATURE REVIEWS IMMUNOLOGY (2003)
Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus
M Saraiva et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
O Martinet et al.
GENE THERAPY (2002)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis
YL Sun et al.
JOURNAL OF IMMUNOLOGY (2002)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor
J Wenzel et al.
FEBS LETTERS (2001)
Phase I study of recombinant human CD40 ligand in cancer patients
RH Vonderheide et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
RM Siegel et al.
SCIENCE (2000)
CD40 ligand (CD154) triggers a short-term CD4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
PJ Blair et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
